DIA China Annual Meeting 2024

Onglee Weng

VP, General Manager at Clario Shanghai

Onglee Weng is the Vice President, General Manager, Clario-Shanghai at Clario. She completed her internal medicine training at Medical School, TongJi University. She was a licensed physician in Shanghai China before joining Clario (and its former companies) over 18 years ago. She successfully established and expanded Clario Cardiac Safety services and Medical Imaging services in China. She and her local team supported the first regulatory mandated Though QT trial in China and trained several national leading phase I centers on ICH E14 compliant trials.​ In her current role, she is the head of Clario Shanghai office, supports cardiovascular safety safety studies in China and the APAC region, business development and provides cardiac safety consultative services.​

Vic Patel, M.D.

VP and Chief Medical Officer, Cardiology at Clario

Vic Patel, M.D., Ph.D., is board certified in cardiology with a PhD in Biophysics and done extensive research on mechanisms of cardiac arrhythmias. He was on faculty at U. Penn. School Medicine for 11 years where he directed Molecular Arrhythmia Research and practiced clinical electrophysiology. Dr. Patel then moved into drug development and cardiac safety as a clinical development leader and therapy area head across all phases.  

At Clario, Dr. Patel oversees cardiology consulting and ECG/Holter core lab services, while leading the biostatistics and medical writing groups. He works with our global customers to ensure their needs are met with robust, cost-effective solutions.